P03.04 Phase II Study of TKIs as Neo(adjuvant) Therapy in Stage II–III Resectable NSCLC with ALK, ROS1, NTRK or BRAFV600 Alterations

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

16

Issue :

3, Number 3 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs55599413

Full Text :

https://doi.org/10.1016/j.jtho.2021.01.377